Harte-Hanks launches health and wellness agency True

Share this article:
Harte-Hanks launches health and wellness agency True
Harte-Hanks launches health and wellness agency True
Harte-Hanks, the direct marketing giant, is looking to break off a piece of the burgeoning health and wellness market with the launch of True Health + Wellness.

The shop, launching with a staff of 20-40 and business from existing clients, will be co-located with the company's consumer CRM shop, The Agency Inside Harte-Hanks, in Yardley, PA, and will be headed by managing director Anne Stroup and creative director Anthony Rotolo. Stroup was previously head of the pharma division at The Agency Inside Harte Hanks, while Rotolo was previously an EVP, creative director at Draftfcb Healthcare.

The launch is an effort to expand beyond the company's heritage in digital and CRM, Stroup told MM&M.

“What we're offering is a full-service brand advertising agency,” Stroup said. “We've always been in health and wellness, we've been in pharmaceutical, but we see pharma moving into this customer-centric model, and we've identified a gap in the available agency services to take the brand and make it relevant on the individual level.”  

By housing True Health + Wellness with The Agency Inside Harte-Hanks, Stroup said the healthcare shop will be able to leverage learnings from its larger consumer CRM sibling and adapt them to the pharma regulatory environment.

With a staff of around 200, The Agency Inside Harte-Hanks handles clients from the automotive, financial services and consumer packaged good sectors.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...